@IPOtweet

Follow us for IPO news and insights. Renaissance puts the new economy to work in investors' portfolios through Pre-IPO research and IPO-focused ETFs.

 Stamford, CT
renaissancecapital.com
Joined June 2009
  • Tweets26.2K
  • Following550
  • Followers27.4K
1.3KMedia
SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO $AHJKU $IPO #IPO zpr.io/D7D5J4QVj3me

SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO

Aimei Health Technology II, the second blank check company formed by two China-based investors targeting small-cap health tech, raised the proposed deal size for its upcoming IPO on Monday.The New...

renaissancecapital.com
1
930
Big breakthroughs happen where technologies converge: AI + robotics, biotech, cloud, connectivity. Chapter 3 of The New AI Stock Edge introduces a “convergence radar” for spotting companies creating new markets. Out Dec 8. Pre-order: amazon.com/dp/B0GY1TQFWG #TheNewAIStockEdge
1
759
Laser-based uranium enrichment developer LIS Technologies files for a $17 million IPO $LIS $IPO #IPO zpr.io/SLpJLzUmDskQ

Laser-based uranium enrichment developer LIS Technologies files for a $17 million IPO

LIS Technologies, which develops laser-based uranium enrichment technologies for nuclear energy, filed on Monday with the SEC to raise up to $17 million in an initial public offering.

renaissancecapital.com
1
3
968
AI model developer Anthropic PBC files for an estimated $75 billion IPO, teeing up one of the largest-ever IPOs for mid-November $ANT $IPO #IPO zpr.io/hKJ2DdjJ7iPZ

AI model developer Anthropic PBC files for an estimated $75 billion IPO, teeing up one of the...

Anthropic PBC, a developer of a foundational LLM known for its AI assistant Claude, filed on Monday with the SEC to raise what we estimate could be $75 billion in an initial public offering.

renaissancecapital.com
900
US IPO Week Ahead: Africa-focused fintech targets US IPO as Anthropic makes its filing public $OPAY $BBTX $ASPE $ANT $IPO #IPO zpr.io/6jCpKNTdWVEB

US IPO Week Ahead: Africa-focused fintech targets US IPO as Anthropic makes its filing public

Updated Monday, 10/26.Three IPOs are currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO.Africa-focused digital bank and fintech...

renaissancecapital.com
1
815
Renaissance Capital retweeted
Yahoo Finance
@YahooFinance13h
“It would be ridiculous to say that there won’t be demand for this,” Renaissance Capital’s Avery Marquez says on Anthropic’s IPO and why what comes after the listing depends on how it’s priced.
4
4
20
13,699
Senior strategist Matt Kennedy and director of investment strategies Avery Marquez will be joining @gammaprime tomorrow, live at 3pm ET. Join the conversation here: xitter.cf/i/spaces/1nxeLMAzNQqJX #IPO $IPO $IPOS $ANT

1
804
The US #IPO Market Winners & Losers Last Week - October 25, 2026. This week’s big news: what didn’t happen. No public filing from Anthropic as fresh volatility gripped AI stocks. 𝘳𝘦𝘢𝘥 𝘰𝘯... renaissancecapital.com/IPO-C… #ipo #iponews
1
810
The International #IPO Market Winners & Losers Last Week - October 25, 2026. International markets traded off further this week, amid global AI worries. 𝘳𝘦𝘢𝘥 𝘰𝘯... renaissancecapital.com/IPO-C… #ipo #iponews
1
777
Wow this Anthropic prospectus looks like it was written by AI... $ANT #IPO sec.gov/Archives/edgar/data/…
1
6
1,132
ANTHROPIC S-1 is LIVE. Read it here: sec.gov/Archives/edgar/data/…
2
6
1,667
Parkinson’s disease biotech Aspen Neuroscience sets terms for $150 million IPO $ASPE $IPO #IPO zpr.io/tA7XnNkBqnsC

Parkinson’s disease biotech Aspen Neuroscience sets terms for $150 million IPO

Aspen Neuroscience, a Phase 1/2a biotech developing stem cell therapies for Parkinson’s disease, announced terms for its IPO on Monday.The San Diego, CA-based company plans to raise $150 million by...

renaissancecapital.com
3
1,202
Immunology and inflammation biotech Bambusa Therapeutics sets terms for $150 million IPO $BBTX $IPO #IPO zpr.io/7Cx5gpbesykD

Immunology and inflammation biotech Bambusa Therapeutics sets terms for $150 million IPO

Bambusa Therapeutics, a Phase 2 biotech developing bispecific antibodies for inflammatory diseases, announced terms for its IPO on Monday.The Boston, MA-based company plans to raise $150 million by...

renaissancecapital.com
1
2
1,123
US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off $RZRA $WWB $SNSG.RC $ISTL $IPO #IPO zpr.io/Yq93GFVYZHYF

US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off

One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings.Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at...

renaissancecapital.com
1
1,102
US IPO Week Ahead: Africa-focused fintech target’s week sole IPO as Anthropic nears its public filing $OPAY $IPO #IPO zpr.io/h7NYJK4NdhCG

US IPO Week Ahead: Africa-focused fintech target’s week sole IPO as Anthropic nears its public...

One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO.Africa-focused digital bank and fintech platform OPay (OPAY) plans...

renaissancecapital.com
1
1,150
SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO $BHAIU $IPO #IPO zpr.io/SUUU4n4jF3er

SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO

BHAV Acquisition II, a blank check company targeting robotics, EVs, fintech, advanced computing and energy tech, lowered the proposed deal size for its upcoming IPO on Friday.The Piscataway, NJ-based...

renaissancecapital.com
2
1,244
Emerging markets fintech OPay sets terms for $320 million US IPO $OPAY $IPO #IPO zpr.io/gszDmmmPWbt4

Emerging markets fintech OPay sets terms for $320 million US IPO

OPay, a digital bank and fintech platform in Nigeria and other emerging markets, announced terms for its IPO on Friday.The Singapore-based company plans to raise $320 million by offering 16 million...

renaissancecapital.com
1
1,232
Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO $WWB $IPO #IPO zpr.io/MsxZ8aXe6sAb

Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO

Windward Bio Group, a Switzerland-based Phase 2/3 biotech developing antibodies for respiratory and dermatologic diseases, filed on Friday with the SEC to raise up to $100 million in an initial...

renaissancecapital.com
1
1,394
From Pre-IPO to Public. Who Really Gets the Upside? Tuesday, October 27, 7 PM UTC Matt Kennedy and Avery Marquez of @IPOtweet Hosted by @GammaEvan Set a reminder 👇 xitter.cf/i/spaces/1nxeLMAzNQqJX
3
2
563
Did you know? If investor demand is weak, an IPO may be listed day-to-day, meaning pricing could be delayed until demand improves. Learn more at IPO Center: renaissancecapital.com/IPO-C… #IPO #NewStock $IPO $IPOS
1
895
Load more